Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
After administration, necessary therapeutic effects may occur, and adverse reactions may also be triggered. Not all adverse reactions will manifest. If any adverse reaction occurs,···【more】
Article source：Captain MedicineRelease date：2026-02-05Recommended：144
Some medications are absolutely contraindicated for combined use. For other medications, even if drug interactions may occur, they can still be used under the guidance of a physici···【more】
Article source：Captain MedicineRelease date：2026-02-05Recommended：168
Cabozantinib is a non-chemotherapy prescription medication classified as a tyrosine kinase inhibitor (TKI). It is administered as a tablet, taken once daily, or as directed by a he···【more】
Article source：Captain MedicineRelease date：2026-02-05Recommended：177
Patients should take pirfenidone with meals at a fixed time every day to reduce the incidence of adverse reactions such as nausea and dizziness. For patients taking strong or moder···【more】
Article source：Captain MedicineRelease date：2026-02-04Recommended：217
The most common side effects of pirfenidone include upper respiratory tract infection, fatigue, headache, dizziness, decreased appetite, sinusitis, insomnia, and weight loss.Are th···【more】
Article source：Captain MedicineRelease date：2026-02-04Recommended：163
Pirfenidone is an oral antifibrotic medication primarily used for the treatment of idiopathic pulmonary fibrosis (IPF).Drug Interactions of PirfenidoneCYP1A2 InhibitorsConcomitant ···【more】
Article source：Captain MedicineRelease date：2026-02-04Recommended：177
The safety of pirfenidone has been evaluated in more than 1,400 subjects, of whom over 170 received pirfenidone treatment for more than 5 years in clinical trials.Precautions for U···【more】
Article source：Captain MedicineRelease date：2026-02-04Recommended：216
Nintedanib is a multi-targeted tyrosine kinase inhibitor; it can reduce the activity of fibroblasts in patients with idiopathic pulmonary fibrosis (IPF).What should be noted during···【more】
Article source：Captain MedicineRelease date：2026-02-03Recommended：198
In 2019, nintedanib became the first therapy approved by the FDA to slow the rate of lung function decline in adults with SSc-ILD.What side effects may occur with nintedanib?The fo···【more】
Article source：Captain MedicineRelease date：2026-02-03Recommended：222
Nintedanib is a small-molecule tyrosine kinase inhibitor that binds to growth factor receptors and inhibits the proliferation of fibroblasts.How to Take NintedanibTake this medicat···【more】
Article source：Captain MedicineRelease date：2026-02-03Recommended：186
Nintedanib is indicated for the treatment of diseases that cause scarring and hardening of the lungs, leading to breathing difficulties. It acts by inhibiting pathological changes ···【more】
Article source：Captain MedicineRelease date：2026-02-03Recommended：192
Elacestrant is the world’s first approved oral selective estrogen receptor degrader (SERD), indicated for the treatment of adult patients with estrogen receptor-positive (ER+), hum···【more】
Article source：Captain MedicineRelease date：2026-02-02Recommended：205
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：[list:visits]2025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：[list:visits]2024-09-07
In recent years, Laos has gradually become a major global supply source for generic drugs, leveragin···【more】
Recommended：[list:visits]2026-22-07
Lucius version of Dacomitinib is now availableCutaneous adverse reactions and management strategies ···【more】
Recommended：[list:visits]2026-21-07
Company Overview: Industrial Migration from India to LaosLucius Pharmaceuticals (Laos) Co., Ltd. was···【more】
Recommended：[list:visits]2026-20-07
Lucius Pharmaceutical is one of the representative generic drug enterprises in Laos. The company was···【more】
Recommended：[list:visits]2026-17-07
Industrial Rise: From Zero to a "World Pharmacy" CandidateThe explosive growth of Laos'···【more】
Recommended：[list:visits]2026-16-07
In recent years, Laos generic drugs have gradually come into view of oncology and chronic disease pa···【more】
Recommended：[list:visits]2026-15-07
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
